Should Low- And Middle-Income Countries Adopt Clinical Guidelines Developed in ‘Rich’ Countries?
PharmacoEconomics - United Kingdom
doi 10.1007/s40273-018-0666-x
Full Text
Open PDFAbstract
Available in full text
Date
June 7, 2018
Authors
Publisher
Springer Science and Business Media LLC